ArticlePediatric research2026
Nonlinear dose-response of umbilical cord blood IL-6 to severe brain injury in preterm infants: a prospective cohort study.
Article in Pediatric research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundUmbilical cord blood IL-6 is implicated in preterm brain injury, but prior studies often assumed linearity, potentially masking complex relationships. We aim to investigate the relationship and threshold effects between umbilical cord blood IL-6 and cerebral injury risk in preterm infants.
methodsThis prospective cohort study enrolled 1028 very preterm infants (VPIs) below 32 weeks. Severe Brain Injury (SBI) or death was the primary outcome. IL-6 was measured in umbilical cord serum. Restricted cubic spline (RCS) regression assessed linearity and identified inflection points, with adjustments for key confounders.
resultsThe risk of cerebral injury started to increase significantly at 7.27 pg/mL (adjusted odds ratio [aOR] = 1.512). RCS revealed a significant nonlinear relationship (P<sub>nonlinear< or sub > < 0.05) with the threshold at 49.09 pg/mL. Below this threshold, each 1-unit increase in IL-6 may raise the risk odd of cerebral injury by 2.6% (aOR = 1.026). Above 49.09 pg/mL, the risk curve plateaued.
conclusionsUmbilical cord blood IL-6 shows a sigmoidal, threshold-dependent relationship with SBI risk. IL-6 > 49.09 pg/ml identify infants at substantially elevated risk, supporting its potential use as a biomarker for early risk stratification. Clinical validation in larger studies is warranted. IMPACT: The IL-6 level in the umbilical cord blood shows a nonlinear, threshold-dependent association with cerebral injury in preterm infants, with the risk ratio plateauing above 49.09 pg/mL. This is the first large cohort study using RCS to depict a sigmoidal IL-6-injury relationship, overcoming limitations of linear/dichotomous models in prior works. IL-6 > 49.09 pg/mL may serve as a clinically applicable biomarker for early identification of high-risk preterm infants, which may guide neuroprotective strategies.
Identifiers
42108333What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.